Advertisement
Research Article

Prolonged Grief Disorder: Psychometric Validation of Criteria Proposed for DSM-V and ICD-11

  • Holly G. Prigerson mail,

    Holly_Prigerson@dfci.harvard.edu

    Affiliations: Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School Center for Palliative Care, Boston, Massachusetts, United States of America

    X
  • Mardi J. Horowitz,

    Affiliation: Department of Psychiatry, University of California School of Medicine, San Francisco, California, United States of America

    X
  • Selby C. Jacobs,

    Affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America

    X
  • Colin M. Parkes,

    Affiliation: St. Christopher's Hospice, Sydenham, and St. Joseph's Hospice, Hackney, England

    X
  • Mihaela Aslan,

    Affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

    X
  • Karl Goodkin,

    Affiliations: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America

    X
  • Beverley Raphael,

    Affiliation: Department of Population Mental Health and Disasters, University of Western Sydney Medical School, New South Wales, Australia

    X
  • Samuel J. Marwit,

    Affiliation: Department of Psychology, University of Missouri, St. Louis, Missouri, United States of America

    X
  • Camille Wortman,

    Affiliation: Department of Psychology, State University of New York at Stony Brook, New York, United States of America

    X
  • Robert A. Neimeyer,

    Affiliation: Department of Psychology, The University of Memphis, Memphis, Tennessee, United States of America

    X
  • George Bonanno,

    Affiliation: Department of Counseling and Clinical Psychology, Teachers College, Columbia University, New York, New York, United States of America

    X
  • Susan D. Block,

    Affiliations: Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School Center for Palliative Care, Boston, Massachusetts, United States of America

    X
  • David Kissane,

    Affiliation: Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Paul Boelen,

    Affiliation: Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands

    X
  • Andreas Maercker,

    Affiliation: Department of Clinical Psychology, University of Zürich, Zürich, Switzerland

    X
  • Brett T. Litz,

    Affiliations: Veterans Affairs Boston Healthcare System, Boston, Massachusetts, United States of America, National Center for PTSD, Boston, Massachusetts, United States of America, Boston University School of Medicine, Boston, Massachusetts, United States of America

    X
  • Jeffrey G. Johnson,

    Affiliation: Department of Psychiatry, Columbia University, New York, New York, United States of America

    X
  • Michael B. First,

    Affiliation: Department of Psychiatry, Columbia University, New York, New York, United States of America

    X
  • Paul K. Maciejewski

    Affiliations: Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

    X
  • Published: August 04, 2009
  • DOI: 10.1371/journal.pmed.1000121

Reader Comments (2)

Post a new comment on this article

why limit PGD?

Posted by ss975 on 25 Aug 2009 at 19:38 GMT

Why should PGD be limited to just those who have lost someone through death? What about children who have been left behind by a parent, person whose significant other has left them, etc. These people also may be feeling extreme grief for extended periods of time. Inclusion of these populations may make your study stronger and allow for a wider population to attain diagnosis and treatment. Are there drugs to help with extreme grief? If not, should some be identified? Maybe drug identification would be included with the same efforts of PGD inclusion in the DSM-V and ICD-11 diagnosis guidelines (?).

No competing interests declared.